Post-approval studies (Phase 4)Study completedNCT00726713
What this trial is testing
Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
Who this might be right for
Type 2 Diabetic Peripheral Neuropathy (DPN)
Pamlab, Inc. 214